We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Maureen Gannon

Maureen Gannon PhD

Associate Dean for Faculty Development, Professor of Medicine, Vanderbilt University Medical Center; Professor of Molecular Physiology and Biophysics and Cell and Developmental Biology, Vanderbilt University, Nashville, Tennessee

Maureen Gannon grew up in Queens, New York, USA. She received her B.S. in Biology from Molloy College in Rockville Centre, NY and her M.S. in Biology from Adelphi University in Garden City, NY. She received her Ph.D. in Cell Biology and Anatomy from Cornell University in 1995. Dr. Gannon pursued postdoctoral training at Vanderbilt University, where she studied the role of the Pdx1 and HNF6 transcription factors in pancreas development. She is currently Professor in the Department of Medicine and Associate Dean of Faculty Development at Vanderbilt University Medical Center. She has developed career development and mentoring programs for Assistant and Associate professor level faculty. Dr. Gannon has secondary appointments in the Departments of Molecular Physiology & Biophysics and Cell & Developmental Biology. Her laboratory focuses on the regulation of pancreatic beta cell mass during development and postnatally in response to physiological and pathological stimuli. Her research has been funded by JDRF, NIH, ADA, and the VA. Her hobbies include Irish Step Dancing, singing, guitar, and camping.

Disclosures

Dr. Gannon has no relevant disclosures.

Recent Contributions to PracticeUpdate:

  1. Pancreatic β-cells in Type 1 and Type 2 Diabetes Mellitus